Diabetes Dictating Policy: An Editorial Commemorating

World Health Day 2016 by Takian, Amirhossein & Kazempour-Ardebili, Sara
Diabetes Dictating Policy: An Editorial Commemorating 
World Health Day 2016
Amirhossein Takian1,2,3, Sara Kazempour-Ardebili4*
Abstract
The 21st century is an era of great challenge for humankind; we are combating terrorism, climate change, 
poverty, human rights issues and last but not least non-communicable diseases (NCDs). The burden of the latter 
has become so large that it is being recognized by world leaders globally as an area that it is in need of much 
greater attention. In light of this concern, the World Health Organization (WHO) dedicated this year’s World 
Health Day (held on April 7, 2016) to raising international awareness on diabetes, the fastest growing NCD in 
the world. This editorial is an account of the macro politics in place for fighting diabetes, both internationally 
and nationally. 
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Diabetes is a leading public health concern worldwide, and despite years of research and development on diabetes care and prevention, it is still one of the 
fastest growing conditions in the world; according to the 
World Health Organization (WHO) the number of people 
living with diabetes has quadrupled since 1980 and in 2014 
there were an estimated 422 million adults with diabetes in 
the world.1 This is a staggering statistic; to better put this 
number into perspective, diabetes can be addressed as the 
third most populated country in the world, after China 
and India.2 The rise in worldwide diabetes prevalence has 
mirrored the rise in overweight and obesity, with a greater 
increase in these conditions in low- and middle-income 
countries.3 Unfortunately, the WHO Eastern Mediterranean 
Region, to which Iran belongs to, is now the world leader in 
increasing diabetes prevalence.4
But why is diabetes important? Because it is a lifelong 
condition, with no established definite cure, has costly 
short- and long-term complications, can lead to premature 
death and disability. In other words, it is very expensive. 
There are direct medical costs, which include expenditure 
on prevention, treatment and management of complications. 
These encompass outpatient, inpatient, emergency care, long-
term care, medications and medical devices. There are also 
indirect costs, which are associated with loss of productivity, 
premature death and disability and a negative impact on the 
countries’ gross domestic product (GDP). While calculation 
of indirect health costs is difficult and quite complex, the 
annual direct health costs associated with diabetes has been 
estimated in a recent meta-analysis to be US$825 billion 
globally.5,6 
All of this is a testament to the need for global action where 
diabetes is concerned. The importance of addressing the 
problem of diabetes has been emphasized by the WHO in 
naming the 2016 World Health Day ‘Beat Diabetes.’ This is 
a campaign that aims to increase awareness about the rising 
prevalence of diabetes and trigger a specific set of actions 
for combating diabetes. The WHO has also launched its 
first Global Diabetes Report on this day, a document that 
outlines not only the importance of battling diabetes, but 
also a framework for surveillance, prevention, and effective 
management of the condition. 
Diabetes is one of four non-communicable diseases (NCDs) 
targeted in the 2011 Political Declaration on the Prevention 
and Control of NCDs (the other three are cardiovascular 
disease, cancer, and chronic respiratory diseases), which 
recognizes the need for population-wide, multisectoral 
interventions to prevent and reduce NCDs. In 2013, a 
comprehensive Global Monitoring Framework was developed 
and adopted by the World Health Assembly (WHA), which 
included nine voluntary targets to be reached by member states 
2025: a 25% reduction in mortality caused by cardiovascular 
disease, diabetes, cancer, and chronic respiratory diseases, 
10% reduction in alcohol abuse, 10% reduction in physical 
inactivity, 30% reduction in salt intake, 30% reduction in 
smoking, 25% reduction in high blood pressure or halt the 
increase in high blood pressure (depending on national 
circumstances), halt the rise in diabetes and obesity, 
expansion of preventive cardiovascular treatment (including 
glycemic control) to at least 50% of eligible population and 
80% availability of affordable basic technologies and essential 
medicines for the treatment of the aforementioned four 
NCDs.7 The framework was accompanied by the WHO NCD 
Global Action Plan, endorsed by the 66th World Health 
Assembly, which provides guidance on policies that help 
achieve the ambitious targets set in the framework.8 
NCDs, including diabetes, have also been recognized as a 
threat to sustainable development and thus, addressed in the 
2030 Agenda for Sustainable Development, adopted by world 
leaders at the 2015 United Nations Development Summit. The 
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In a recent contribution to the ongoing debate about the role of power in global health, Gorik Ooms emphasizes the normative underpinnings of global health politics. 
He identifies three related problems: (1) a lack of agreement 
among global health scholars about their normative premises, 
(2) a lack of agreement between global health scholars and 
policy-makers regarding the normative premises underlying 
policy, and (3) a lack of willingness among scholars to 
clearly state their normative premises and assumptions. This 
confusion is for Ooms one of the explanations “w y global 
health’s policy-make s are not implementing the knowledge 
gen rated by global health’s empir cal schol rs.” H  calls 
for great r u ity between schol rs and between scholars 
and policy-makers, concerning the underlying normative 
premises and greater openness when it comes to advocacy.1
We commend the effort to reinstate power and politics in 
global health and agree that “a purely empirical evidence-based 
approach is a fiction,” and that such a view risks covering up 
“the role of politics and power.” But by contrasting this fiction 
with global health research “driven by crises, hot issues, and 
the concerns of organized interest groups,” as a “path we are 
trying to move away from,” Ooms is submitting to a liberal 
conception of politics he implicitly criticizes the outcomes 
of.1 A liberal view of politics evades the constituting role of 
conflicts nd reduces it to eith r a rationalistic, economic 
alculation, or an individual questi n of moral norms. This 
is echoed in Ooms when he stat s that “it is not possible to 
discuss the politics of global health without discussi g the 
normative premises behind the politics.”1 But what if we 
take the political as the primary level and the normative as 
secondary, or derived from the political?
That is what we will try to do here, by introducing an 
alternative conceptualization of the political and hence free 
us from the “false dilemma” Ooms also wants to escape. 
“Although constructivists have emphasized how underlying 
normative structures constitute actors’ identities and 
interests, they have rarely treated these normative structures 
themselves as defined and infused by power, or emphasized 
how constitutive effects als  are expressions of power.”2 This 
is the starting point fo  the political theorist Chantal Mouffe,
a d her respo se is to develop an tological conception of
th  political, where “the political belongs to our ontological 
condition.”3 According to Mouffe, society is instituted 
through conflict. “[B]y ‘the political’ I mean the dimension of 
antagonism which I take to be constitutive of human societies, 
while by ‘politics’ I mean the set of practices and institutions 
through which an order is created, organizing human 
coexistence in the context of conflictuality provided by the 
political.”3 An issue or a topic needs to be contested to become 
political, and such a contestation concerns public action and 
creates a ‘we’ and ‘they’ form of collective identification. But 
the fixation of social relations is partial and precarious, since 
antagonism is an ever present possibility. To politicize an issue 
and be able to mobilize support, one needs to represent the 
world in a conflictual manner “with opposed camps with
which people c n identify.”3 
Ooms uses the case of “increasing international aid spending 
on AIDS treatment” to illustrate his point.1 He frames the 
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 a rece t c tri ti  t  t e g i g e ate a t t e 
r le f er i  gl al ealt , rik s e asizes 
t e r ative er i i gs f gl al ealt  litics. 
e i e tifies t ree relate  r le s: (1) a lack f agree e t 
a g gl al ealt  sc lars a t t eir r ative re ises, 
(2) a lack f agree e t et ee  gl al ealt  sc lars a  
licy- akers regar i g t e r ative re ises erlyi g 
licy, a  (3) a lack f illi g ess a g sc lars t  
clearly state t eir r ative re is s a  a ti s. is 
c f si  is f r s e f t e ex a ati s “ y gl al 
ealt ’s licy- ake s are t i le e ti g t e k le ge 
ge erate  y gl al ealt ’s e irical sc lars.” e calls 
f r greater nity et ee  sc lars a  et ee  sc lars 
a  licy- akers, c cer i g t e erlyi g r ative 
re ises a  greater e ess e  it c es t  a v cacy.1
e c e  t e eff rt t  rei state er a  litics i  
gl al ealt  a  agree t at “a rely e irical evi e ce- ase  
a r ac  is a ficti ,” a  t at s c  a vie  risks c veri g  
“t e r le f litics a  er.” t y c trasti g t is ficti  
it  gl al ealt  researc  “ rive  y crises, t iss es, a  
t e c cer s f rga ize  i terest gr s,” as a “ at  e are 
tryi g t  ve a ay fr ,” s is s itti g t  a li eral 
c ce ti  f litics e i licitly criticizes t e tc es 
f.1  li eral vie  f litics eva es t  c stit ti g r le f 
c flicts  re ces it t  eit r a rati alistic, ec ic 
alc lati , r a  i ivi al esti  f ral r s. is 
is ec e  i  s e  e states t at “it is t ssi le t  
isc ss t e litics f gl al ealt  it t isc ssing t e 
r ative re ises e i  t e litics.”1 t at if e 
take t e litical as t e ri ary level a  t e r ative as 
sec ary, r erive  fr  t e litical?
at is at e ill try t   ere, y i tr ci g a  
alter ative c ce t alizati  f t e litical a  e ce free 
s fr  t e “false ile a” s als  a ts t  esca e. 
“ lt g  c str ctivists ave e asize   erlyi g 
r ative str ct res c stit te act rs’ i e tities a  
i terests, t ey ave rarely treate  t ese r ative str ct res 
t e selves as efi e  a  i f se  y er, r e asize
 c stit tive effects als  ar  ex ssi s f er.”2 is
is t e starti g i t f  t e litical t e rist a tal ffe, 
an  er res nse is t  evel  a  ont l gical c ce ti  f 
t e litical, ere “t e litical el gs t  r t l gical 
c iti .”3 cc r i g t  ffe, s ciety is i stit te  
t r g  c flict. “[ ]y ‘t e litical’ I ea  t e i e si  f 
a tag is  ic  I take t  e c stit tive f a  s cieties, 
ile y ‘ litics’ I ea  t e set f ractices a  i stit ti s 
t r g  ic  a  r er is create , rga izi g a  
c existe ce i  t e c text f c flict ality r vi e  y t e 
litical.”3  iss e r a t ic ee s t  e c teste  t  ec e 
litical, a  s c  a c testati  c cer s lic acti  a  
creates a ‘ e’ a  ‘t ey’ f r  f c llective i e tificati . t 
t e fixati  f s cial relati s is artial a  recari s, si ce 
a tag is  is a  ever rese t ssi ility.  liticize a  i s e
a  e a le t  ilize s rt, e ee s t  re rese t t e
rl  i  a c flict al a er “ it  se  ca s it  
ic  e le ca  i e tify.”3 
s ses t e case f “i creasi g i ter ati al ai  s e i g 
 I S treat e t” t  ill strate is i t.1 e fra es t e 
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Agenda includes 17 Sustainable Development Goals (SDGs), 
the third of which addresses good health and well-being for 
all. Among the objectives set for this goal, member states 
have committed to ‘reduce premature mortality from NCDs 
through prevention and treatment by one third by 2030,’ which 
mirrors the first voluntary target set in the Global Monitoring 
Framework for NCDs. By recognizing NCDs as an obstacle for 
sustainable development and pledging to globally combat its 
effects, world leaders have effectively raised the much needed 
awareness of society as a whole towards the importance of 
worldwide solidarity against NCDs.9
It is difficult to find a country that does not already have a 
national diabetes plan, which underscores the enormity of 
the global concern surrounding it. However, many nations 
among those with lower incomes lack proper funding and 
implementation of such plans and policies. The WHO Global 
Action Plan for Prevention and Control of NCDs8 outlines 
six specific objectives and recommends effective policies 
for achieving those objectives and ultimately attaining 
the NCD prevention and control targets set by the Global 
Monitoring Framework. These objectives are: (1) to prioritize 
(to a greater extent) NCD prevention and control in global, 
regional, and national agendas and internationally agreed 
development goals; (2) to strengthen the national capacity in 
order to enhance national response for NCD prevention and 
control; (3) to create, sustain and expand health-promoting 
environments to reduce modifiable risk factors (namely 
tobacco use, diet, physical activity and alcohol abuse); (4) to 
strengthen and orient the health systems to address NCDs 
through people-centered primary healthcare and universal 
health coverage; (5) to promote high quality research and 
development; and (6) to monitor trends and determinants 
and evaluate progress. By adopting these policies and tailoring 
them to their population’s needs, nations can move a step 
closer to tackling NCDs, and among them diabetes. 
As one of the countries in the Eastern Mediterranean Region, 
the world’s fastest growing hub of diabetes, Iran is a country 
of 78.8 million population with the second largest economy 
in the Middle East (after Saudi Arabia), and an estimated 
GDP of US$393.7 billion, categorizing it as an upper middle-
income country.10 The current life expectancy in Iran is 74 
years, with 64 years healthy life expectancy.11 The greatest 
burden of disease, as calculated by disability-adjusted life-
years (DALYs) is attributed to cardiovascular disease and 
diabetes. NCDs in general are responsible for 76% of total 
deaths in the country, with diabetes and cardiovascular 
disease directly responsible for at least 48% of total deaths.11 
A large portion of the deaths caused by diabetes may be 
prevented by better control of the condition, which relies on 
increasing awareness and compliance among the patients and 
advocating self-care, areas in which many Iranian patients are 
sorely lacking. The Iranian government has long recognized 
the nation’s vulnerability to NCDs and numerous national 
plans, programs and policies have been implemented over the 
years with little effect on reducing NCD burden. To effectively 
overcome this burden, specific and clear policies are needed 
not only to prevent diabetes, but also to optimize diabetic 
patients’ control; this can be achieved by developing national 
and local guidelines and auditing their use and misuse on 
regular basis, as well as holding healthcare professionals 
responsible when targets are not met.
Following the WHO’s call for global action against NCDs, an 
Iranian National Committee for NCD Prevention and Control 
was formed, chaired by the Minister of Health and Medical 
Education (MoHME), and adopted by the Supreme Council 
of Health and Food Security, which is a multidisciplinary 
council including 3 vice-presidents and 10 ministers across 
the government. The national committee is a policy-making, 
regula tory, scientific, and planning committee that has 
subcommittees to perform its duties in all areas related to the 
control of NCDs and risk factors; the committee is regarded 
as a decision-making body of the MoHME with respect 
to NCDs. This committee has produced the first National 
Action Plan for the prevention and control of NCDs,12 which 
includes the voluntary targets set by the Global Monitoring 
Framework and goes a step further by adding 4 new targets 
that are specific to national circumstances: zero trans fatty 
acid in food products, 20% relative reduction in mortality due 
to traffic injuries, 10% relative reduction in mortality due to 
drug abuse, and 20% increase in access to treatment for mental 
diseases. The Action Plan has also changed the targets for 
reducing physical inactivity from 10% to 20% and expansion 
of preventive cardiovascular treatment to at least 70% instead 
of the WHO’s proposed 50% of eligible population.12
The Iranian National Action Plan for the Prevention and 
Control of NCDs sets out ambitious targets and specific 
recommendations for attaining those targets. Whether 
implementing the program and its related policies will be 
feasible and/or effective in the nation’s war against NCDs 
remains to be seen. There are undoubtedly numerous 
obstacles hindering the achievement of these targets, not 
least of which is securing the required financial resources 
needed in an era of resilient economy, as well as the need 
for safeguarding peoples’ health and well-being in the post-
sanctions Iran, where further Westernization threatens to 
increase the prevalence of NCD risk factors. Ambitious 
targets, limited resources and rising risk factors; these entities 
summarize the challenge of facing NCDs not only in Iran, but 
in every developing nation around the globe. Therefore, how 
Iran goes forward and what it achieves from adopting and 
building on the United Nations Development Programme 
(UNDP), WHA, and WHO agendas for tackling NCDs will 
undoubtedly be of immense educational value not only to its 
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